These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 37537342)
1. The DUBA-SLC7A11-c-Myc axis is critical for stemness and ferroptosis. Wang Z; Ouyang L; Liu N; Li T; Yan B; Mao C; Xiao D; Gan B; Liu S; Tao Y Oncogene; 2023 Sep; 42(36):2688-2700. PubMed ID: 37537342 [TBL] [Abstract][Full Text] [Related]
2. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Koppula P; Zhuang L; Gan B Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412 [TBL] [Abstract][Full Text] [Related]
3. SHP-1/STAT3-Signaling-Axis-Regulated Coupling between BECN1 and SLC7A11 Contributes to Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma. Huang CY; Chen LJ; Chen G; Chao TI; Wang CY Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232407 [TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma with high expression of SLC7A11 is sensitive to erastin-induced ferroptosis. Zhang W; Li Q; Zhang Y; Wang Z; Yuan S; Zhang X; Zhao M; Zhuang W; Li B Apoptosis; 2024 Apr; 29(3-4):412-423. PubMed ID: 38001343 [TBL] [Abstract][Full Text] [Related]
5. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma. Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946 [TBL] [Abstract][Full Text] [Related]
6. Suppression of the SLC7A11/glutathione axis causes ferroptosis and apoptosis and alters the mitogen-activated protein kinase pathway in nasopharyngeal carcinoma. Wang HH; Fan SQ; Zhan YT; Peng SP; Wang WY Int J Biol Macromol; 2024 Jan; 254(Pt 3):127976. PubMed ID: 37951442 [TBL] [Abstract][Full Text] [Related]
7. The CRL3 Zhou Q; Yu H; Chen Y; Ren J; Lu Y; Sun Y Proc Natl Acad Sci U S A; 2024 Jul; 121(28):e2320655121. PubMed ID: 38959043 [TBL] [Abstract][Full Text] [Related]
8. Loss of PERK function promotes ferroptosis by downregulating SLC7A11 (System Xc⁻) in colorectal cancer. Saini KK; Chaturvedi P; Sinha A; Singh MP; Khan MA; Verma A; Nengroo MA; Satrusal SR; Meena S; Singh A; Srivastava S; Sarkar J; Datta D Redox Biol; 2023 Sep; 65():102833. PubMed ID: 37536085 [TBL] [Abstract][Full Text] [Related]
9. Ferroptosis and Neurodegenerative Diseases: Insights into the Regulatory Roles of SLC7A11. Wang C; Liu H; Xu S; Deng Y; Xu B; Yang T; Liu W Cell Mol Neurobiol; 2023 Aug; 43(6):2627-2642. PubMed ID: 36988772 [TBL] [Abstract][Full Text] [Related]
10. Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11. Wang X; Chen Y; Wang X; Tian H; Wang Y; Jin J; Shan Z; Liu Y; Cai Z; Tong X; Luan Y; Tan X; Luan B; Ge X; Ji H; Jiang X; Wang P Cancer Res; 2021 Oct; 81(20):5217-5229. PubMed ID: 34385181 [TBL] [Abstract][Full Text] [Related]
11. CircRPPH1 promotes the stemness of gastric cancer cells by targeting miR-375/SLC7A11 axis. Liu J; Yang H; Deng J; Jiang R; Meng E; Wu H Environ Toxicol; 2023 Jan; 38(1):115-125. PubMed ID: 36190453 [TBL] [Abstract][Full Text] [Related]
12. AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP/SLC7A11 signaling pathway. Chen J; Zhang J; Tian W; Ge C; Su Y; Li J; Tian H Mol Carcinog; 2023 Jun; 62(6):833-844. PubMed ID: 36920042 [TBL] [Abstract][Full Text] [Related]
13. The ubiquitin hydrolase OTUB1 promotes glioma cell stemness via suppressing ferroptosis through stabilizing SLC7A11 protein. Zhao X; Zhou M; Yang Y; Luo M Bioengineered; 2021 Dec; 12(2):12636-12645. PubMed ID: 34927544 [TBL] [Abstract][Full Text] [Related]
14. TXNDC12 knockdown promotes ferroptosis by modulating SLC7A11 expression in glioma. Yu H; Zhu K; Wang M; Jiang X Clin Transl Sci; 2023 Oct; 16(10):1957-1971. PubMed ID: 37503932 [TBL] [Abstract][Full Text] [Related]
15. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma. Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976 [TBL] [Abstract][Full Text] [Related]
16. Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis. Xu X; Zhang X; Wei C; Zheng D; Lu X; Yang Y; Luo A; Zhang K; Duan X; Wang Y Eur J Pharm Sci; 2020 Sep; 152():105450. PubMed ID: 32621966 [TBL] [Abstract][Full Text] [Related]
17. The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11. Liu T; Jiang L; Tavana O; Gu W Cancer Res; 2019 Apr; 79(8):1913-1924. PubMed ID: 30709928 [TBL] [Abstract][Full Text] [Related]
18. The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment. He J; Wang X; Chen K; Zhang M; Wang J Biochem Pharmacol; 2022 Nov; 205():115241. PubMed ID: 36084707 [TBL] [Abstract][Full Text] [Related]
19. PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer. Hong T; Lei G; Chen X; Li H; Zhang X; Wu N; Zhao Y; Zhang Y; Wang J Redox Biol; 2021 Jun; 42():101928. PubMed ID: 33722571 [TBL] [Abstract][Full Text] [Related]
20. Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation. Shi Z; Li Z; Jin B; Ye W; Wang L; Zhang S; Zheng J; Lin Z; Chen B; Liu F; Zhang B; Ding X; Yang Z; Shan Y; Yu Z; Wang Y; Chen J; Chen Q; Roberts LR; Chen G Clin Transl Med; 2023 Jun; 13(6):e1300. PubMed ID: 37337470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]